MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M
Cannabinoid-Focused Pharma Stock Slides On Q2 Earnings Report, Here Are The Details
MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
David Pidduck Recent News
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
MediPharm Touts Strong Q3 Revenue Growth, Continues To Expand Internationally
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
MediPharm Labs Awarded Payment Of $9.8M By Ontario Court Of Justice
MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
MediPharm Labs Q1 Revenue Slightly Drops, Here Are The Details